Supreme Court to hear arguments on generic fish‑oil pill case, industry watches

The U.S. Supreme Court is set to hear arguments this week on a case involving a prescription‑strength pill derived from fish oil.

The dispute centers on whether the product qualifies as a generic version of an existing drug, a question that could shape how new generics are evaluated and approved.

Industry observers say the outcome may have wide‑reaching effects on the generic market, prompting close attention from manufacturers and investors.